Peptide Purity: What Does 99% Actually Mean?

# **Peptide Purity: What Does 99% Actually Mean on a COA?

If you've ever ordered a research peptide, you've seen a number like "99% purity" on the Certificate of Analysis — but do you know what that number is actually measuring? Understanding peptide purity percentage isn't just a technicality. For researchers working with GLP-1 compounds like Retatrutide or Tirzepatide, that number is the difference between reliable data and compromised results.

## What the Research Actually Shows

Purity percentages on a COA are not a manufacturer's opinion — they are the output of specific analytical instrumentation. The gold standard for measuring peptide purity is High-Performance Liquid Chromatography (HPLC), a technique that physically separates the components of a sample and quantifies each one by its peak area on a chromatogram. The percentage you see — 98%, 99%, or higher — represents the proportion of the total detected material that is the target peptide. Everything else in that sample: truncated sequences, deletion peptides, oxidized byproducts, unreacted reagents — all of that lands in the remaining 1–2%.

A 2021 review published in the *Journal of Pharmaceutical and Biomedical Analysis* confirmed that reverse-phase HPLC (RP-HPLC) remains the most widely adopted method for peptide purity assessment in pharmaceutical and research settings, with UV detection at 214 nm being the standard absorbance wavelength used to capture peptide bond absorption across nearly all amino acid sequences. What this means practically: two peptides with identical sequences but manufactured differently can produce dramatically different chromatographic profiles — and dramatically different biological outcomes in a research context. (Source: *J Pharm Biomed Anal*, 2021 — https://www.sciencedirect.com/journal/journal-of-pharmaceutical-and-biomedical-analysis)

Mass spectrometry (mass spec) is typically run alongside HPLC to confirm molecular identity — not purity. Mass spec tells you that the correct peptide was synthesized; HPLC tells you how much of the sample *is* that peptide. Together, they form the analytical backbone of any credible COA. A recent deep-dive published by *LA Weekly* on pharmaceutical-grade peptide production noted that suppliers cutting corners often present mass spec data without corresponding HPLC data — making it appear more rigorous than it actually is. (Source: LA Weekly, 2025 — https://laweekly.com)

## How It Works

Think of HPLC like a race. You inject your peptide sample into a column packed with a stationary phase material. Different molecules travel through that column at different speeds based on how they interact with the packing material. The target peptide — the one you actually want — exits the column at a predictable time called the retention time. A detector measures how much material exits at each moment, producing a series of peaks on a graph. The largest peak — your target — is divided by the total area of all peaks combined. That ratio, expressed as a percentage, is your purity number.

When a supplier reports 99% purity via HPLC with a valid chromatogram attached to the COA, you can verify this math yourself. When no chromatogram is attached — only a number — you are trusting a claim with no supporting evidence. That distinction matters enormously for research integrity.

## What This Means for You

For researchers studying GLP-1 receptor agonists — including newer dual and triple agonists like Tirzepatide (GIP/GLP-1) and Retatrutide (GIP/GLP-1/glucagon) — the purity of the compound directly affects experimental reproducibility. Impurities at even the 1–2% level can include biologically active fragments that bind to receptors, alter downstream signaling, or introduce confounding variables that make dose-response data unreliable. A 2023 assessment reviewing gray-market peptides circulating online found that a significant proportion failed to meet labeled purity claims when independently tested, underscoring the risk of sourcing from suppliers who cannot produce verifiable HPLC chromatograms. (Source: The Tech Buzz, 2025 — https://thetechbuzz.net)

This is not a minor quality-control footnote. In receptor binding studies, even small concentrations of deletion peptides — sequences missing one or more amino acids — can exhibit partial agonist activity that distorts your results without any obvious experimental signal that something is wrong.

## Key Takeaways

• 99% purity via HPLC means 99% of the detected material in the sample is the target peptide — measured by peak area ratio on a chromatogram, not by the manufacturer's assertion.
• Mass spec confirms identity; HPLC confirms purity. A legitimate COA should include both, with raw chromatogram data attached — not just a summary table.
• Impurities matter for research. Even 1–2% contamination with truncated or modified peptide fragments can introduce biologically active compounds that compromise experimental outcomes.
• Always request the chromatogram. A purity number without supporting chromatographic data is unverifiable — and any reputable supplier should provide it without hesitation.